Device Trial Radar · NCT06486454
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
5,000
Planned (sponsor's estimate)
Start
Oct 14, 2024
Primary completion
Nov 2034
Study completion Nov 2039
Sponsor
- Lead sponsor
- HistoSonics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 3, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to collect information on the use of the HistoSonics Edison System for the treatment of liver tumors. The main aim is to understand how different patient characteristics and procedural characteristics may affect histotripsy success at 36 hours post-histotripsy procedure. Sub-studies to the BOOMBOX: Master Study will investigate specific populations and/or clinical questions with more stringent enrollment criteria, standardized testing criteria, and/or follow-up schedule. Any participant enrolled in the BOOMBOX: Master Study that also qualifies for a sub-study may enroll in the sub-study in parallel; sub-studies will be described in separate sub-study protocols. The BOOMBOX: Master Study will collect information about participants before, during, and after the histotripsy treatment procedure. All participants will be followed per standard clinical follow-up based on each site's clinical practice for up to 5 years after the initial histotripsy procedure or until completion of their follow-up in a sub-study, whichever is longer.
Conditions
- Liver Neoplasms
- Primary Liver Cancer
- Secondary Liver Cancer
- Tumor Liver
- Benign Liver Tumor
Interventions
HistoSonics Edison SystemDevice
Histotripsy with the HistoSonics Edison System for the full or partial destruction of liver tumors
Primary outcomes
What the sponsor says the trial is designed to measure.
- Histotripsy Technical SuccessTime frame: ≤36 hours post-histotripsy treatment procedure
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
University of South Alabama
Mobile, Alabama · Recruiting
Providence St. Jude
Fullerton, California · Recruiting
Cedars-Sinai Medical Center
Los Angeles, California · Recruiting
32 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.